Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Carr

Showing results (121-130 of 289) with videos related to

Pageof 29
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2015
Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With MenRosalind Foster, John McAllister, Tim R Read, et al.
AIDS (London, England)|December 4, 2002
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension studyDon E Smith, Andrew Carr, Matthew Law, et al.
HIV Clinical Trials|May 29, 2002
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 studyMartyn French, Janaki Amin, Norman Roth, et al.
Bone Research|May 8, 2023
Neutralization of excessive levels of active TGF-β1 reduces MSC recruitment and differentiation to mitigate peritendinous adhesionYuSheng Li, Xiao Wang, Bo Hu, et al.
BMC Musculoskeletal Disorders|January 6, 2021
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centreRaja Bhaskara Rajasekaran, Duncan Whitwell, Thomas D A Cosker, et al.
Scientific Reports|February 1, 2024
Absence of lunar phobia in European swarming vespertilionid batsGrzegorz Apoznański, Felix Tuff, Andrew Carr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell countsStephen T Wright, Andrew Carr, Ian Woolley, et al.
AIDS (London, England)|November 5, 2008
Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsAndrew Carr, Armin Ritzhaupt, Wei Zhang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2019
Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label StudyAndrew Carr, Stephen J Kerr, Robyn Richardson, et al.
AIDS (London, England)|March 17, 2017
Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual menJohn W McAllister, Janet M Towns, Anna Mcnulty, et al.
Pageof 29

Showing results (121-130 of 289) with videos related to

Sort By:
Pageof 29
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2015
Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With MenRosalind Foster, John McAllister, Tim R Read, et al.
AIDS (London, England)|December 4, 2002
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension studyDon E Smith, Andrew Carr, Matthew Law, et al.
HIV Clinical Trials|May 29, 2002
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 studyMartyn French, Janaki Amin, Norman Roth, et al.
Bone Research|May 8, 2023
Neutralization of excessive levels of active TGF-β1 reduces MSC recruitment and differentiation to mitigate peritendinous adhesionYuSheng Li, Xiao Wang, Bo Hu, et al.
BMC Musculoskeletal Disorders|January 6, 2021
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centreRaja Bhaskara Rajasekaran, Duncan Whitwell, Thomas D A Cosker, et al.
Scientific Reports|February 1, 2024
Absence of lunar phobia in European swarming vespertilionid batsGrzegorz Apoznański, Felix Tuff, Andrew Carr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell countsStephen T Wright, Andrew Carr, Ian Woolley, et al.
AIDS (London, England)|November 5, 2008
Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsAndrew Carr, Armin Ritzhaupt, Wei Zhang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2019
Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label StudyAndrew Carr, Stephen J Kerr, Robyn Richardson, et al.
AIDS (London, England)|March 17, 2017
Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual menJohn W McAllister, Janet M Towns, Anna Mcnulty, et al.
Pageof 29